Breaking News
Investing Pro 0
Cyber Monday Extended SALE: Up to 60% OFF InvestingPro+ CLAIM OFFER

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday

Stock Markets Sep 28, 2022 11:10
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
 
IXIC
-0.18%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ENRY
-0.80%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Gainers

  • Avenue Therapeutics, Inc. (NASDAQ: ATXI) shares climbed 106.3% to close at $9.15. Avenue Therapeutics recently received the official meeting minutes from the FDA regarding a meeting conducted for IV Tramadol in combination with other opioid analgesics to manage moderate-to-moderately severe pain. Concurrently, Avenue Therapeutics announced that it would effect a 1-for-15 reverse stock split.
  • Scienjoy Holding Corporation (NASDAQ: SJ) climbed 47.9% to close at $2.47 after declining 44% on Monday.
  • Sonendo, Inc. (NASDAQ: SONX) gained 42.7% to close at $1.67. Sonendo recently announced a private placement of common stock and pre-funded warrants, resulting in gross proceeds of $63 million led by a consortium of new and existing investors.
  • X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) gained 40.2% to close at $1.25 after the company announced data from its Phase 1b trial evaluating mavorixafor in chronic neutropenia.
  • Antelope Enterprise Holdings Limited (NASDAQ: AEHL) rose 37.5% to settle at $0.9320.
  • Grove Collaborative Holdings, Inc. (NYSE: GROV) shares surged 35.5% to close at $4.01. Grove Collaborative continued retail expansion with entry into thousands of more stores.
  • InMed Pharmaceuticals Inc. (NASDAQ: INM) climbed 31.3% to close at $6.71. InMed recently reported a FY22 net loss of $33.17 per share.
  • AN2 Therapeutics, Inc. (NASDAQ: ANTX) gained 31.1% to close at $15.50.
  • FingerMotion, Inc. (NASDAQ: FNGR) climbed 30.3% to close at $1.0592 after rising around 20% on Monday.
  • Intelligent Living Application Group Inc. (NASDAQ: ILAG) gained 28.4% to close at $2.62 after gaining over 11% on Monday.
  • Harrow Health, Inc. (NASDAQ: HROW) gained 27.9% to close at $9.73 after the company announced the FDA has approved IHEEZO 3% for ocular surface anesthesia.
  • Presto Automation, Inc. (NASDAQ: PRST) jumped 24% to close at $2.69.
  • Equillium, Inc. (NASDAQ: EQ) climbed 22.8% to close at $2.37. Equillium announced interim results from the Type B portion of the EQUALISE study evaluating itolizumab in patients with lupus nephritis (LN).
  • Lion Group Holding Ltd. (NASDAQ: LGHL) rose 22.8% to close at $2.10.
  • PaxMedica, Inc. (NASDAQ: PXMD) gained 18.4% to close at $2.57 as the company issued a corporate update after IPO. The company named Stephen D. Sheldon as CFO.
  • Latch, Inc. (NASDAQ: LTCH) rose 18.1% to close at $1.01.
  • Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) gained 18% to close at $1.14. Bellerophon announced FDA acceptance of change to ongoing Phase 3 REBUILD study of INOpulse for the treatment of fibrotic interstitial lung disease.
  • Metacrine, Inc. (NASDAQ: MTCR) rose 17.7% to settle at $0.4975.
  • Altus Power, Inc. (NASDAQ: AMPS) gained 17.1% to close at $13.90 after the company announced definitive agreements to acquire approximately 97 megawatts of operating solar assets.
  • SenesTech, Inc. (NASDAQ: SNES) jumped 15.2% to close at $0.4290. SenesTech, last month, posted a Q2 loss of $0.21 per share.
  • Ryder System, Inc. (NYSE: R) rose 14.7% to close at $76.28 following a Bloomberg report suggesting Apollo is said to explore a takeover of the company.
  • Third Harmonic Bio, Inc. (NASDAQ: THRD) gained 14.3% to close at $19.93. The company recently priced its IPO at $17 per share.
  • Avalon GloboCare Corp. (NASDAQ: AVCO) climbed 13.6% to close at $0.4999.
  • Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 13.5% to close at $0.2538. Ensysce Biosciences recently announced initiation of second human abuse potential study, being conducted by Dr. Vince Clinical Research.
  • Maxeon Solar Technologies, Ltd. (NASDAQ: MAXN) climbed 12.7% to close at $24.40.
  • Skillz Inc. (NYSE: SKLZ) jumped 12.5% to close at $1.08.
  • Vertex (NASDAQ:VRTX) Energy, Inc. (NASDAQ: VTNR) gained 12.3% to settle at $6.11.
  • Unico American Corporation (NASDAQ: UNAM) rose 11.6% to close at $1.3951.
  • BIT Mining Limited (NYSE: BTCM) climbed 11.6% to close at $0.2902 after declining around 9% on Monday.
  • The Beauty Health Company (NASDAQ: SKIN) climbed 11.4% to close at $11.58 after the company announced a $200 million buyback.
  • Milestone Scientific Inc. (NASDAQ: MLSS) rose 10.5% to close at $0.7540.
  • Vermilion Energy Inc. (NYSE: VET) gained 10.4% to close at $20.32.
  • Verve Therapeutics, Inc. (NASDAQ: VERV) rose 10.1% to close at $34.28.
  • CVR Energy, Inc. (NYSE: CVI) climbed 9.5% to close at $27.99.
  • Biocept, Inc. (NASDAQ: BIOC) rose 8.8% to close at $0.87.
  • Novonix Limited (NASDAQ: NVX) gained 7.9% to close at $5.31.
  • Stryve Foods, Inc. (NASDAQ: SNAX) jumped 7.7% to close at $0.4326.
  • Foghorn Therapeutics Inc. (NASDAQ: FHTX) gained 7.2% to close at $8.15.
  • BitNile Holdings, Inc. (NYSE: NILE) rose 6.7% to close at $0.1975.
  • Novavax, Inc. (NASDAQ: NVAX) gained 6.2% to settle at $20.04. Novavax announced an initial one million doses of Nuvaxovid are available for use in the UK.

Losers

  • NLS Pharmaceutics AG (NASDAQ: NLSP) dropped 23.4% to settle at $0.7201. NLS Pharmaceutics announced topline results from its Phase 2a trial evaluating its lead product candidate, Quilience (Mazindol ER), in narcolepsy.
  • Midatech Pharma plc (NASDAQ: MTP) fell 20.8% to close at $2.06.
  • FedNat Holding Company (NASDAQ: FNHC) shares dropped 19.9% to close at $0.18 on Tuesday after dropping over 15% on Monday.
  • Kintara Therapeutics, Inc. (NASDAQ: KTRA) fell 19.5% to settle at $0.1098. Kintara Therapeutics posted a Q4 loss of $0.52 per share.
  • Eve Holding, Inc. (NYSE: EVEX) dropped 18.5% to close at $10.02. BLADE India signed non-binding order for up to 200 eVTOL vehicles from Eve Air Mobility.
  • Ocular Therapeutix, Inc. (NASDAQ: OCUL) dropped 18.4% to close at $4.31. Ocular Therapeutix announced interim 7-month data from its U.S. Phase 1 trial evaluating OTX-TKI for wet age-related macular degeneration (wet AMD) and other retinal diseases.
  • Golden Sun Education Group Limited (NASDAQ: GSUN) fell 17.5% to close at $33.58.
  • Exicure, Inc. (NASDAQ: XCUR) fell 17.1% to close at $1.41. Exicure announced restructuring plans and aligned resources to continue exploring strategic alternatives. The company will cut its workforce by approximately 66%, expected to be completed by the fourth quarter of 2022.
  • Austin Gold Corp. (NYSE: AUST) dropped 16.5% to close at $0.8798.
  • NuZee, Inc. (NASDAQ: NUZE) fell 15.7% to settle at $0.4010.
  • FaZe Holdings Inc. (NASDAQ: FAZE) fell 15.3% to close at $12.50.
  • Nano Labs Ltd (NASDAQ: NA) dropped 15.2% to close at $3.18.
  • Mondee Holdings, Inc. (NASDAQ: MOND) dipped 15% to settle at $8.82.
  • Evaxion Biotech A/S (NASDAQ: EVAX) fell 12.7% to close at $2.40. Evaxion Biotech recently announced it reached an important milestone announcing today that it had enrolled its first patient in the global phase 2b clinical trial of EVX-01.
  • Provident Financial (LON:PFG) Services, Inc. (NYSE: PFS) fell 12.5% to close at $20.27. Provident Financial Services and Lakeland Bancorp to merge in an all-stock transaction.
  • Kronos Worldwide, Inc. (NYSE: KRO) dropped 12.4% to close at $9.36. Barclays (LON:BARC) maintained Kronos Worldwide with an Underweight and lowered the price target from $15 to $8.
  • SAI.TECH Global Corporation (NASDAQ: SAI) dropped 12.2% to close at $4.19.
  • 374Water, Inc. (NASDAQ: SCWO) declined 11.6% to settle at $3.05.
  • Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) fell 11.5% to close at $0.9294. Ayala Pharmaceuticals announced the FDA has granted Fast Track designation for AL102 for the treatment of progressing desmoid tumors.
  • Troika Media Group, Inc. (NASDAQ: TRKA) shares fell 11.4% to close at $0.3344 after declining 6% on Monday.
  • Avidity Biosciences, Inc. (NASDAQ: RNA) shares fell 10.9% to close at $16.70. The FDA has placed a partial clinical hold on new participant enrollment in Avidity Biosciences’ Phase 1/2 MARINA trial of AOC 1001 in adults with myotonic dystrophy type 1 (DM1).
  • Minerva Surgical, Inc. (NASDAQ: UTRS) fell 10% to close at $0.7650.
  • Vipshop Holdings Limited (NYSE: VIPS) fell 10% to close at $8.38.
  • Polar Power, Inc. (NASDAQ: POLA) declined 9.8% to close at $2.85 after gaining around 25% on Monday.
  • AMTD Digital Inc. (NYSE: HKD) shares fell 8.4% to close at $59.54.
  • Inpixon (NASDAQ: INPX) fell 8% to close at $0.1295. Inpixon shares jumped over 21% on Monday after the company announced it signed a definitive merger agreement with KINS Technology for KINS to acquire Inpixon's enterprise apps business.
  • Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares fell 7.8% to close at $6.60. Kiora Pharmaceuticals said its stockholders authorized a reverse stock split of its common stock.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email